The goal of this clinical trial is to evaluate whether a trauma-informed, artificial intelligence-supported chatbot can reduce psychological distress and unmet psychosocial needs in adults newly diagnosed with cancer.:
* Does the chatbot reduce trauma-related distress and anxiety levels compared to standard care? * Does the chatbot decrease unmet psychosocial needs in patients following a new cancer diagnosis? Researchers will compare the chatbot intervention to standard care to determine whether the chatbot provides additional psychosocial benefit.
Participants will:
* Be randomly assigned to either the chatbot intervention group or the standard care group * Use the chatbot freely for 12 weeks (intervention group only) * Complete questionnaires at baseline, 1 month, and 3 months * Be monitored for any psychological risk indicators during the study period
Over 18 years of age,
Able to speak and understand Turkish,
Without any cognitive, visual, or auditory impairments,
Diagnosed with cancer within the last month (Stage I, II, and III) (regardless of cancer type),
Patients participating in another simultaneous psychosocial/digital intervention study,
Patients diagnosed with advanced stage (Stage IV) cancer, in the terminal phase and with metastases,
Patients diagnosed with schizophrenia, bipolar disorder, substance abuse, depression and anxiety disorders will be excluded.
Koç University
Lead sponsor
The Scientific and Technological Research Council of Turkey
Collaborator